In conclusion, the increased expression of IL36G in VAT of patients with obesity and CC underscores its importance in the tumour microenvironment and suggests that the inflammatory milieu and the remodelling of the ECM associated with obesity may drive the upregulation of IL-36 signalling pathways, which are known to contribute to tumorigenesis (Fig. 5). Here, IL36G is linked to obesity disorder.